Alternative routes of insulin delivery, including intraperitoneal and inhaled insulin, are being investigated and the more rapid absorption compared to the subcutaneous route may counteract postprandial hyperglycemia and minimize hypoglycemia [85,86]. The gene discussed is INS; the disease is Hyperglycemia.